Investment analysts at Loop Capital initiated coverage on shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in a research report issued to clients and investors on Thursday. The firm set a “buy” rating and a $95.00 price target on the pharmacy operator’s stock. Loop Capital’s price target suggests a potential upside of 17.10% from the stock’s current price.

Several other research firms have also commented on WBA. Morgan Stanley reiterated an “overweight” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Citigroup Inc. reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 3rd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Finally, Jefferies Group LLC dropped their price target on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, May 31st. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $91.06.

Shares of Walgreens Boots Alliance (NASDAQ WBA) opened at 81.13 on Thursday. The firm has a market capitalization of $86.82 billion, a price-to-earnings ratio of 20.49 and a beta of 1.25. The company has a 50-day moving average price of $79.95 and a 200 day moving average price of $82.28. Walgreens Boots Alliance has a 1-year low of $75.18 and a 1-year high of $89.69. Walgreens Boots Alliance also saw unusually large options trading on Thursday. Stock traders bought 21,284 call options on the stock. This represents an increase of approximately 753% compared to the average daily volume of 2,495 call options.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the business posted $1.18 earnings per share. On average, equities research analysts predict that Walgreens Boots Alliance will post $5.00 EPS for the current year.

Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase program on Thursday, June 29th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s leadership believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/26/loop-capital-initiates-coverage-on-walgreens-boots-alliance-inc-wba.html.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 13.50% of the company’s stock.

A number of institutional investors have recently modified their holdings of WBA. Russell Investments Group Ltd. increased its position in shares of Walgreens Boots Alliance by 72.9% in the first quarter. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator’s stock worth $40,115,000 after buying an additional 203,635 shares during the period. Sumitomo Mitsui Asset Management Company LTD increased its position in shares of Walgreens Boots Alliance by 9.3% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 75,821 shares of the pharmacy operator’s stock worth $6,296,000 after buying an additional 6,462 shares during the period. Welch & Forbes LLC increased its position in shares of Walgreens Boots Alliance by 4.8% in the first quarter. Welch & Forbes LLC now owns 96,882 shares of the pharmacy operator’s stock worth $8,046,000 after buying an additional 4,453 shares during the period. SpiderRock Advisors LLC acquired a new position in shares of Walgreens Boots Alliance during the first quarter worth approximately $301,000. Finally, Orrstown Financial Services Inc. increased its position in shares of Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 213 shares during the period. 61.16% of the stock is owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.